Alpine Immune Sciences Secures $48,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6053acb4-85d8-4e9d-a38f-099eed851f71
Date
6/14/2016
Company Name
Alpine Immune Sciences
Mailing Address
600 Stewart St. Seattle, WA 98101 USA
Company Description
Alpine Immune Sciences (AIS) was founded in 2015 and seed funded by Alpine BioVentures. AIS is focused on developing novel protein – based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology.
Website
http://www.alpineimmunesciences.com
Transaction Type
Venture Equity
Transaction Amount
$48,000,000
Transaction Round
Series A
Proceeds Purposes
We believe this significant funding, along with our collective expertise, will enable us to discover and develop clinically meaningful and transformative therapies for patients.
M&A Terms
Venture Investor
OrbiMed
Venture Investor
Frazier Healthcare Partners
Venture Investor
Alpine Technology Fund